Treatment of Postoperative Delirium
Modern classification defines postoperative delirium as an acute disturbance of consciousness with reduced ability to focus, sustain or shift attention, which is accompanied by changes in perception. The etiology of postoperative delirium is not fully understood and is likely multifactorial. Reduced activity of gamma-aminobutyric acid, abnormal metabolism of melatonin and serotonin along with noradrenaline hyperproduction leads to increased release of interleukin-1 (IL-1) and IL-6, which results in damage to neurons and cerebral hypoperfusion that is a possible pathogenetic mechanism. Postoperative delirium occurs in patients undergoing surgical procedures and anesthesia, usually within 1–3 days. The incidence of postoperative delirium is 10–24 % in all hospitalized patients, and 37–46 % in surgical patients. In the intensive care units, the incidence of postoperative delirium is reported to be 87 %. In general, the incidence of delirium in the postoperative period varies widely: from 9 to 87 %, depending on the patient’s age and type of operation. The degree of operational stress to some extent affects the development of delirium. In addition, reduced intellectual ability in the preoperative period and chronic illnesses are independent predictors of postoperative delirium in elderly people. Today, among the methods of medical treatment and prevention of postoperative delirium, the use of haloperidol and chlorpromazine is proved. There is a sufficient number of individual and multicenter studies confirming the efficacy of first-generation antipsychotics. Sufficient evidence base allows the use of these drugs, when studying new drugs, as a standard and in terms of their well-known and provided clinical effect. Despite the pathognomonic role of acetylcholinesterase in creating conditions for postoperative delirium, the clinical efficacy of acetylcholinesterase inhibitors remains controversial. Today, the positive impact of rivastigmine, donepezil and galantamine on the incidence of delirium is not proven during their use both in preoperative and postoperative period. That is, the search for new drugs and prevention schemes remains very topical issue of anesthesiology today.
Full Text:PDF (Українська)
Morandi A. Understanding international differences in terminology for delirium and other types of acute brain dysfunction in critically ill patients / Morandi A, Pandharipande P, Trabucchi M // Intensive Care Medicine. — 2016. — V. 34. — P. 1907-15.
Inouye S.K. Risk factors for delirium at discharge: development and validation of a predictive model / Inouye SK, Zhang Y, Jones RN // Archive Internum Medicine. — 2014. — V. 167. — P. 1406-13.
Hshieh T.T. Cholinergic deficiency hypothesis in delirium: a synthesis of current evidence / Hshieh TT, Fong TG, Marcantonio ER, Inouye SK // Journal Gerontology A Biology Science Medicine. — 2014. — V. 63. — P. 764-72.
Maldonado JR. Pathoetiological model of delirium:a comprehensive understanding of the neurobiology of delirium and an evidence-based approach to prevention and treatment / Maldonado JR // Critical Care Clinical. — 2014. — V. 24. — P. 789-856.
Radtke FM. Risk factors for inadequate emergence after anesthesia:emergence delirium and hypoactive emergence / Radtke FM, Franck M, Hagemann L, Seeling M // Minerva Anestesiology. — 2013. — V. 76. — P. 394-403.
Yu D. Emergence agitation in adults: risk factors in 2,000 patients / Yu D, Chai W, Sun X, Yao L // Canadian Journal Anaesthesiology. — 2010. — V. 57. — P. 843-848.
Bryson GL. Methods and madness: agitation, delirium, and postoperative cognitive dysfunction / Bryson GL // Canadian Journal Anaesthiology. — 2010. — V. 57. — P. 799-803.
Maldonado JR. Delirium in the acute care setting: characteristics, diagnosis and treatment / Maldonado JR // Critical Care Clinical. — 2013. — V. 24. — P. 657-722.
Greene NH. Measures of executive function and depression identify patients at risk for postoperative delirium / Greene NH, Attix DK, Weldon BC // Anesthesiology. — 2009. — V. 110. — P. 788-795.
Lat I. The impact of delirium on clinical outcomes in mechanically ventilated surgical and trauma patients / Lat I, McMillian W, Taylor S, Janzen JM // Critical Care Medicine. — 2012. — V. 37. — P. 1898-1905.
Gonzalez M. Impact of delirium on short-term mortality in elderly inpatients: a prospective cohort study / Gonzalez M, Martinez G, Calderon J, Villarroel L // Psychosomatics. — 2009. — V. 50. — P. 234-238.
Rudolph JL. Delirium: an independent predictorfunctional decline after cardiac surgery / Rudolph JL, Inouye SK, Jones RN // Journal American Geriatric. — 2013. — V. 58. — P. 643-649.
Pisani MA. Days of delirium are associated with 1-year mortality in an older intensive care unit population / Pisani MA, Kong SY, Kasl SV, Murphy TE // American Journal Respirator Critical Care Medicine. — 2014. — V. 180. — P. 1092-1097.
Shehabi Y. Delirium duration and mortality in lightly sedated, mechanically ventilated intensive care unit patients / Shehabi Y, Riker RR, Bokesch PM // Critical Care Medicine. — 2014. — V. 38. — P. 2311-2318.
Witlox J. Delirium in elderly patients and the risk of postdischarge mortality, institutionalization, and dementia / Witlox J, Eurelings LS, de Jonghe JF // Journal American Medicine. — 2014. — V. 304. — P. 443-451.
Leslie DL. One-year health care costs associated with delirium in the elderly population / Leslie DL, Marcantonio ER, Zhang Y, Leo-Summers L // Archive Internum Medicine. — 2013. — V. 168. — P. 27-32.
Bagri AS. Evaluation and management of the elderly patient at risk for postoperative delirium / Bagri AS, Rico A, Ruiz JG // Clinical Geriatric Medicine. — 2012. — V. 24. — P. 667-686.
Yang FM. Phenomenological subtypes of delirium in older persons: patterns, prevalence, and prognosis / Yang FM, Marcantonio ER, Inouye SK // Psychosomatics. — 2012. — V. 50. — P. 248-254.
- There are currently no refbacks.
Copyright (c) 2017 EMERGENCY MEDICINE
This work is licensed under a Creative Commons Attribution 4.0 International License.
© Publishing House Zaslavsky, 1997-2018